Euda Health Holdings Limited - Ordinary Shares (EUDA)
2.3400
+0.00 (0.00%)
NASDAQ · Last Trade: Dec 30th, 6:44 AM EST
Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.
Via Chartmill · December 24, 2025
The trading volume of these stocks is deviating from the norm in today's session.
Via Chartmill · December 24, 2025
Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · December 24, 2025
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · November 5, 2025
Via Benzinga · October 28, 2025
Via Benzinga · October 24, 2025
Via Benzinga · October 13, 2025
Via Benzinga · October 1, 2025
Via Benzinga · September 11, 2025
Via Benzinga · September 4, 2025
Via Benzinga · August 26, 2025
Via Benzinga · August 8, 2025
Via Benzinga · May 14, 2025

Via Benzinga · July 4, 2024

Via Benzinga · May 7, 2024

Gainers
Via Benzinga · November 1, 2023

Via Benzinga · September 12, 2023

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for Combination of Opioids and N-Acylethanolamines for pain treatment.
Via Benzinga · October 31, 2023

Via Benzinga · August 22, 2023

Via Benzinga · July 19, 2023

Via Benzinga · July 18, 2023

During Tuesday's trading, 46 companies set new 52-week lows.
Via Benzinga · July 18, 2023

Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring.
Via Benzinga · July 18, 2023

Via Benzinga · July 18, 2023

Gainers Biophytis S.A. (NASDAQ: BPTS) shares surged 53.9% to $3.31 in pre-market trading after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's main product.
Via Benzinga · July 18, 2023